VITAL WINGS TO EXPORTS

Vital has created a name in the manufacture and development of bulk actives surreptitiously. Its area of core competence (API’s) backed by tireless efforts has made ‘Vital’ a preferred supplier in global export arena. It is recognized as a “STAR EXPORT HOUSE”.

Efforts are afoot to increase the market base in the large and remunerative European markets, for which ‘Vital’ has accelerated the ‘EUDMF’ filing programmes to build & nurture the new and existing clientele. EUDMF for Quinine Sulphate and Quinine Hydrochloride have already gained approvals by being awarded the Certificate of Suitability (COS) by the European Directorate for the Quality of Medicines and Healthcare (EDQM)  

‘Vital’ has seen exports grow over the last 3 years. Contribution of exports to overall turnover is now almost 50%. By middle of 2010, we hope to have accreditation of USFDA APPROVAL.

With these key factors in progress, ‘Vital’ shall see a substantial growth in exports in the years to come, resulting into rise in contribution of exports significantly to overall turnover.

Vital’s international coverage to various countries by way of export includes United Kingdom, Germany, Korea, Hong Kong, Bangladesh, Dubai, Syria, Turkey, Sudan, Kenya, Tanzania, Nigeria, Uruguay, Congo, Columbia, USA, China, Mexico, Japan, Pakistan.